Clinical Trial Update: Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma [NA]

View source ↗

Summary

This clinical-trial update reports on the evaluation of valganciclovir for classic, non-HIV-associated Kaposi's sarcoma; the study is completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | NA | Status: COMPLETED | Results posted: 2015-11-25